Start Of A Price War? Guangdong Unveils Harsh Drug Tender Rule Despite Industry Uproar
This article was originally published in PharmAsia News
Executive Summary
The potential impact by Guangdong province could cause broad price erosion and has prompted at least one analyst to downgrade the sector.